AWM Investment Company’s Crinetics Pharmaceuticals CRNX Stock Holding History

AWM Investment Company’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.63M	Hold	100,000	–	–	0.4%	59
2025 Q4	$4.66M	Hold	100,000	–	–	0.45%	63
2025 Q3	$4.17M	Buy	100,000 +5,000	+5%	+$160K	0.39%	63
2025 Q2	$2.73M	Hold	95,000	–	–	0.31%	73
2025 Q1	$3.19M	Buy	95,000 +40,000	+73%	+$1.49M	0.44%	59
2024 Q4	$2.81M	Hold	55,000	–	–	0.34%	60
2024 Q3	$2.81M	Hold	55,000	–	–	0.34%	63
2024 Q2	$2.46M	Hold	55,000	–	–	0.33%	64
2024 Q1	$2.57M	Buy	55,000 +5,000	+10%	+$196K	0.34%	64
2023 Q4	$1.78M	Buy	50,000 +35,000	+233%	+$1.07M	0.23%	77
2023 Q3	$446K	Buy	+15,000	New	+$309K	0.07%	96

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AWM Investment Company's CRNX Position: Q1 2026 in Review

AWM Investment Company held its Crinetics Pharmaceuticals (CRNX) position steady in Q1 2026 at 100,000 shares worth $3.63M. The position accounts for 0.4% of the portfolio, ranked #59.

AWM Investment Company first reported a position in CRNX in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.66M in Q4 2025. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

AWM Investment Company held 100,000 shares of Crinetics Pharmaceuticals worth $3.63M as of Q1 2026.
AWM Investment Company left its Crinetics Pharmaceuticals share count unchanged in Q1 2026.
Crinetics Pharmaceuticals made up 0.4% of AWM Investment Company's portfolio in Q1 2026, its #59 holding.
AWM Investment Company first reported a position in Crinetics Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
AWM Investment Company's Crinetics Pharmaceuticals position peaked at $4.66M in Q4 2025.
243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.